Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Mar;235(4):207-13.
doi: 10.1007/BF00314348.

Antibodies against saline-soluble components of skeletal muscle in myasthenia gravis

Affiliations

Antibodies against saline-soluble components of skeletal muscle in myasthenia gravis

A Komiyama et al. J Neurol. 1988 Mar.

Abstract

Antibodies against phosphate-buffered-saline extracts (SE) of non-acetylcholine receptor (AChR) skeletal muscle antigens were found in patients with myasthenia gravis (MG). The antigenicity of SE was distributed in three fractions with molecular masses of over 200 kDa, 90-150 kDa and 7-14 kDa on gel filtration. These fractions shared common antigenicities. Further analysis of 90-150 kDa fractions on sodium dodecyl sulphate polyacrylamide gel electrophoresis showed five major bands, ranging from 105 kDa to 275 kDa. The antibodies against SE were detected in 52% (58/112) of the MG patients; incidence and titres were higher in the thymoma group (n = 21; 90% and 0.872 respectively) than in the non-thymoma group (n = 91; 43% and 0.200, P less than 0.001). In patients without a thymoma, these antibodies were frequently observed in late-onset disease and the severe generalized form (P less than 0.01). In 4 of 7 ocular MG patients without anti-AChR antibodies, low but appreciable levels of anti-SE antibodies were found. In 73% (11/15) of generalized MG patients treated with prednisolone and thymectomy, anti-SE antibody titres changed in association with those of anti-AChR antibodies and with the clinical course. Both antibody titres increased synchronously in patients who developed crises.

PubMed Disclaimer

Similar articles

References

    1. N Engl J Med. 1965 Sep 16;273(12):615-20 - PubMed
    1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
    1. Clin Exp Immunol. 1972 Mar;10(3):453-61 - PubMed
    1. Clin Exp Immunol. 1970 Jul;7(1):11-21 - PubMed
    1. J Neuroimmunol. 1981 Dec;1(4):421-7 - PubMed

Publication types

LinkOut - more resources